Canyam
Your research section headline
Home
Preprint
Subscribe
Favorites
Blog
Tools
Analysis
Summary
Mobile
WeChat Mini Program
Not logged in
English
Notice
1
Back
T
Therapeutic Advances in Psychopharmacology
IF
4
Papers
436
Citations
1541
Related Insights
0
subscribe
Journal Papers
435
Publication Date
Publication Date
IF
Citations
Lithium-induced blepharospasm in a middle-aged woman with recurrent depressive disorder: a case report
Therapeutic Advances in Psychopharmacology
IF
4
2026-08-05
0
PRE
AI
Maria del Rosario Arevalo Bazalar; Jayamal De Silva
Share
Save
Seizures associated with clozapine augmentation by other antipsychotics: a pharmacovigilance–pharmacodynamic analysis using VigiBase
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-30
0
PRE
AI
Masakazu Hatano; Hirofumi Hamano; Masaya Kanda; Takenao Koseki; Tsuyoshi Nakai; Rina Horii; Nozomi Yoshihara; Takeo Saito; Kenshi Takechi; Satoru Esumi; Yoshito Zamami; Shigeki Yamada
Share
Save
Oestrogen modulators as augmentation to antipsychotics for the treatment of post- and perimenopausal psychosis: a systematic review
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-29
0
PRE
AI
Cassidy Keen; Athanasios Hassoulas; Jill Richardson
Share
Save
Conceptual analysis of mechanisms and methods in psychedelic clinical trial design: a narrative review
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-25
0
PRE
AI
Martin Krsak; David Sparrow; Bernard Rosner; Deborah DeMolles; Scott Shannon
Share
Save
A qualitative exploration of perspectives on taking lithium supplements
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-22
0
PRE
AI
Madeleine Bloomfield; Lily Chebabo-Manning; Rebecca Strawbridge
Share
Save
Lithium in the management of suicide: a formidable force in the fight against a fatal foe
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-21
0
PRE
AI
Gurubhaskar Shivakumar; Kinga Szymaniak; Erica Bell; Gin S. Malhi
Share
Save
Patterns of antidepressant treatment changes among adults with major depressive disorder in Northwest Ethiopia: a hospital-based cross-sectional study
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-15
0
PRE
AI
Tilaye Arega Moges; Fasil Bayafers Tamene; Woretaw Sisay Zewdu; Getachew Yitayew Tarekegn; Asanti Dejen; Tigabu Eskeziya Zerihun; Abel Temeche Kassaw; Desalegn Addis Mussie; Samuel Agegnew Wondm; Abaynesh Fentahun Bekalu; Samuel Berihun Dagnew
Share
Save
Identifying patients at risk of supratherapeutic amisulpride exposure in routine psychiatric practice: a real-world therapeutic drug monitoring study
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-07
0
PRE
AI
Keyu Yan; Gehang Ju; Aowei Li; Ruomei Gao; Na Wang; Qing Shao
Share
Save
Making a case for using MDMA-assisted psychotherapy for borderline personality disorder and complex PTSD: a descriptive systematic review of the literature
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-07
0
PRE
AI
Karthika Kasiviswanathan; Dinuli Nilaweera; Melissa Morando; Sathya Rao; Jessica Lee; Joseph Fettling; Jillian H. Broadbear
Share
Save
Assessment of clozapine taste in healthy volunteers: evidence for non-aversive sensory profile
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-04
0
PRE
AI
Laura Modica de Mohac; Alex Keeley; David Taylor; Catherine Tuleu
Share
Save
Ketamine alters the aperiodic EEG exponent in major depression: implications for cortical E/I balance and treatment prediction
Therapeutic Advances in Psychopharmacology
IF
4
2026-07-03
0
PRE
AI
Yujuan Liu; Xiaorong Liu; Sebastian Olbrich; Chong-Leong Lao; Haoyun Zhang; Martin Brunovsky; Cheng-Teng Ip
Share
Save
Patient-centred education for ketamine and esketamine therapies in mood disorders
Therapeutic Advances in Psychopharmacology
IF
4
2026-06-29
0
PRE
AI
Zofia Kachlik; Wiesław Jerzy Cubała; Michał Walaszek
Share
Save
Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysis
Therapeutic Advances in Psychopharmacology
IF
4
2026-06-29
0
PRE
AI
Damian Swieczkowski; Aleksander Kwaśny; Wiesław Jerzy Cubała
Share
Save
Benzodiazepine receptor agonist deprescribing principles for long-term use and dependence: modified Delphi recommendations from a multi-disciplinary expert panel
Therapeutic Advances in Psychopharmacology
IF
4
2026-06-09
0
PRE
AI
Jaden Brandt; Nicole Lamberson; Jolene Bressi; Alexis Ritvo; Janice Curle; Josef Witt-Doerring; Marjorie DeWert; Steven Wright; Mark Horowitz
Share
Save
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review
Therapeutic Advances in Psychopharmacology
IF
4
2026-06-04
0
PRE
AI
Ewa Okon-Rocha; David Taylor
Share
Save
Adjunctive aripiprazole for amisulpride-induced hyperprolactinemia: a preliminary retrospective study showing no reversing effect
Therapeutic Advances in Psychopharmacology
IF
4
2026-05-27
0
PRE
AI
Xiaoqian Lan; Hongyan Zhuang; Pengfei Li
Share
Save
Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression
Therapeutic Advances in Psychopharmacology
IF
4
2026-05-22
0
PRE
AI
Liliana Patarroyo-Rodriguez; Vanessa K. Pazdernik; Jennifer L. Vande Voort; Simon Kung; Balwinder Singh
Share
Save
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians
Therapeutic Advances in Psychopharmacology
IF
4
2026-05-20
0
PRE
AI
Kristian Beichmann; Polina Catzeflis; Helena D. Aicher; Federico Seragnoli; Abigail Calder; Adam Amrani; Gregor Hasler
Share
Save
Patient views on paliperidone palmitate 3-monthly: a cross-sectional questionnaire in UK community mental health teams
Therapeutic Advances in Psychopharmacology
IF
4
2026-05-19
0
PRE
AI
Ivana Clark; Siobhan Gee; David Taylor
Share
Save
Modafinil-associated psychosis: a systematic review of case characteristics and management strategies
Therapeutic Advances in Psychopharmacology
IF
4
2026-05-10
0
PRE
AI
Yutaro Sato; Atsushi Sakuma; Hiroaki Tomita
Share
Save